Adrián Daneri‐Navarro

1.6k total citations
66 papers, 1.2k citations indexed

About

Adrián Daneri‐Navarro is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Adrián Daneri‐Navarro has authored 66 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 15 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Adrián Daneri‐Navarro's work include Immune Cell Function and Interaction (11 papers), BRCA gene mutations in cancer (10 papers) and Cancer Risks and Factors (6 papers). Adrián Daneri‐Navarro is often cited by papers focused on Immune Cell Function and Interaction (11 papers), BRCA gene mutations in cancer (10 papers) and Cancer Risks and Factors (6 papers). Adrián Daneri‐Navarro collaborates with scholars based in Mexico, United States and Spain. Adrián Daneri‐Navarro's co-authors include Alicia Del Toro‐Arreola, Susana del Toro‐Arreola, Maria Guadalupe Ramírez‐Dueñas, Trinidad García‐Iglesias, Alejandro Bravo‐Cuéllar, Pedro Ernesto Sánchez‐Hernández, Antonio Topete, Luz-Ma-Adriana Balderas-Peña, Pablo Cesar Ortiz‐Lazareno and Josué Juárez and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Adrián Daneri‐Navarro

61 papers receiving 1.2k citations

Peers

Adrián Daneri‐Navarro
Manoj K. Mishra United States
Meghdad Abdollahpour‐Alitappeh Iran
Amy V. Paschall United States
Guiying Zhang China
Yi Chen China
Camillo Palmieri Italy
Ying Yue China
Suat‐Cheng Peh Malaysia
Tianzhou Liu China
Manoj K. Mishra United States
Adrián Daneri‐Navarro
Citations per year, relative to Adrián Daneri‐Navarro Adrián Daneri‐Navarro (= 1×) peers Manoj K. Mishra

Countries citing papers authored by Adrián Daneri‐Navarro

Since Specialization
Citations

This map shows the geographic impact of Adrián Daneri‐Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrián Daneri‐Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrián Daneri‐Navarro more than expected).

Fields of papers citing papers by Adrián Daneri‐Navarro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrián Daneri‐Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrián Daneri‐Navarro. The network helps show where Adrián Daneri‐Navarro may publish in the future.

Co-authorship network of co-authors of Adrián Daneri‐Navarro

This figure shows the co-authorship network connecting the top 25 collaborators of Adrián Daneri‐Navarro. A scholar is included among the top collaborators of Adrián Daneri‐Navarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrián Daneri‐Navarro. Adrián Daneri‐Navarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saldaña-Cruz, Ana Míriam, et al.. (2025). TP53 IVS3 16 bp Variant and Breast Cancer Risk in Western Mexican Women: A Case–Control Study. Current Issues in Molecular Biology. 47(9). 744–744.
2.
Topete, Antonio, et al.. (2024). The VEGFA rs3025039 Variant Is a Risk Factor for Breast Cancer in Mexican Women. International Journal of Molecular Sciences. 25(18). 10172–10172.
3.
Toro‐Arreola, Alicia Del, et al.. (2023). HLA-G 14 bp Ins/Del (rs66554220) Variant Is Not Associated with Breast Cancer in Women from Western Mexico. Current Issues in Molecular Biology. 45(8). 6842–6850. 1 indexed citations
4.
5.
Mercado, Mónica Vázquez-Del, Erika Aurora Martínez-García, Adrián Daneri‐Navarro, et al.. (2021). Presence of anti-TIF-1γ, anti-Ro52, anti-SSA/Ro60 and anti-Su/Ago2 antibodies in breast cancer: a cross-sectional study. Immunopharmacology and Immunotoxicology. 43(3). 328–333. 8 indexed citations
6.
Blazer, Kathleen R., Yanin Chávarri-Guerra, Cynthia Villarreal‐Garza, et al.. (2021). Development and Pilot Implementation of the Genomic Risk Assessment for Cancer Implementation and Sustainment (GRACIAS) Intervention in Mexico. JCO Global Oncology. 7(7). 992–1002. 10 indexed citations
7.
8.
Toro‐Arreola, Alicia Del, et al.. (2020). The −174G>C and −596G>A Polymorphisms Are Not Associated with Circulating IL-6 Levels in Breast Cancer Patients from Jalisco, México. Genetic Testing and Molecular Biomarkers. 24(4). 224–228. 4 indexed citations
9.
Topete, Antonio, et al.. (2020). Selective estrogen receptor modulators in the prevention of breast cancer in premenopausal women: a review. Translational Cancer Research. 9(7). 4444–4456. 10 indexed citations
10.
Almada, Mario, Josué Juárez, Abraham Zepeda‐Moreno, et al.. (2019). Cisplatin-loaded PLGA nanoparticles for HER2 targeted ovarian cancer therapy. Colloids and Surfaces B Biointerfaces. 178. 199–207. 67 indexed citations
11.
García-García, Maritza Roxana, et al.. (2018). Adhesion, proliferation, and apoptosis in different molecular portraits of breast cancer treated with silver nanoparticles and its pathway-network analysis. International Journal of Nanomedicine. Volume 13. 1081–1095. 18 indexed citations
12.
Toro‐Arreola, Alicia Del, et al.. (2018). Preparation of PLGA/Rose Bengal colloidal particles by double emulsion and layer-by-layer for breast cancer treatment. Journal of Colloid and Interface Science. 518. 122–129. 21 indexed citations
13.
Roca-Chiapas, José María De la, et al.. (2017). Validation of Health Behavior and Stages of Change Questionnaire. Breast Cancer Targets and Therapy. Volume 9. 199–205. 18 indexed citations
14.
Daneri‐Navarro, Adrián, et al.. (2017). Evaluation of psychosocial aspects in participants of cancer genetic counseling. Hereditary Cancer in Clinical Practice. 15(1). 13–13. 6 indexed citations
15.
Nodora, Jesse, Gregory A. Talavera, Linda C. Gallo, et al.. (2015). Acculturation, Behavioral Factors, and Family History of Breast Cancer among Mexican and Mexican-American Women. Women s Health Issues. 25(5). 494–500. 13 indexed citations
16.
Jave‐Suárez, Luis Felipe, Pablo Cesar Ortiz‐Lazareno, Alejandro Bravo‐Cuéllar, et al.. (2012). Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications. BMC Immunology. 13(1). 7–7. 21 indexed citations
17.
Mercado, Mónica Vázquez-Del, et al.. (2011). Intracellular antigens released from Balb/c mice kidneys under chemically induced apoptosis and/or necrosis. Reumatismo. 60(2). 108–13. 2 indexed citations
18.
Martínez-García, Erika Aurora, Pedro Ernesto Sánchez‐Hernández, Beatriz Teresita Martín-Márquez, et al.. (2010). The Distribution of CD56dimCD16+ and CD56brightCD16− Cells are Associated with Prolactin Levels during Pregnancy and Menstrual Cycle in Healthy Women. American Journal of Reproductive Immunology. 65(4). 433–437. 8 indexed citations
19.
Flores‐Romo, Leopoldo, et al.. (2009). Immunobiology of HPV Infection. Archives of Medical Research. 40(6). 443–448. 10 indexed citations
20.
Daneri‐Navarro, Adrián, Susana del Toro‐Arreola, Pedro Ernesto Sánchez‐Hernández, et al.. (2005). Immunosuppressive activity of proteases in cervical carcinoma. Gynecologic Oncology. 98(1). 111–117. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manoj K. Mishra Breakdown of academic impact, for papers by Meghdad Abdollahpour‐Alitappeh Breakdown of academic impact, for papers by Amy V. Paschall Breakdown of academic impact, for papers by Guiying Zhang Breakdown of academic impact, for papers by Yi Chen Breakdown of academic impact, for papers by Camillo Palmieri Breakdown of academic impact, for papers by Ying Yue Breakdown of academic impact, for papers by Suat‐Cheng Peh Breakdown of academic impact, for papers by Tianzhou Liu
Rankless by CCL
2026